AKT/mTORC2 inhibition activates FOXO1 function in CLL cells reducing B cell receptor-mediated survival
Cosimo, Emilio, Tarafdar, Anuradha, Moles, Michael W, Holroyd, Ailsa K, Malik, Natasha, Catherwood, Mark A., Hay, Jodie, Dunn, Karen M, Macdonald, Alan M, Guichard, Sylvie M, O'Rourke, Declan M, LeachLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-18-2036
Date:
December, 2018
File:
PDF, 3.33 MB
english, 2018